Clinical Trial Update: Metronomic Chemotherapy With Capecitabine for Pancreatic Cancer [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for metronomic chemotherapy with capecitabine in pancreatic cancer (Phase 2 and Phase 3).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Capecitabine (capecitabine)

Snippet

Sponsor: Ruijin Hospital | Conditions: Pancreatic Cancer | Phase 2, Phase 3 | Status: UNKNOWN